CIMBA40 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Company Name | CIMB FTSE ASEAN 40 MALAYSIA |
Stock Name | CIMBA40 |
Date Announced | 7 Apr 2015 |
Category | General Announcement |
Reference No | OB-150407-C34DC |
Type | Announcement |
Subject | NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE |
Description | Fund: CIMB FTSE ASEAN 40 Malaysia Date: 07-Apr-2015 IOPV per unit (RM): 1.8712 Units in circulation (units): 1,350,000.00 Management Fee (% p.a.): 0.00 Trustee Fee (% p.a.): 0.08 Index Licence Fee (% p.a.): 0.00 FTSE/ASEAN 40 Index: 10,889.78 |
CIMBC50 - NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE
Company Name | CIMB FTSE CHINA 50 |
Stock Name | CIMBC50 |
Date Announced | 7 Apr 2015 |
Category | General Announcement |
Reference No | OB-150407-C34C4 |
Type | Announcement |
Subject | NET ASSET VALUE / INDICATIVE OPTIMUM PORTFOLIO VALUE |
Description | Fund: CIMB FTSE China 50 Date: 07-Apr-2015 IOPV per unit (RM): 1.3596 Units in circulation (units): 11,700,000.00 Management Fee (% p.a.): 0.60 Trustee Fee (% p.a.): 0.08 Index Licence Fee (% p.a.): 0.04 FTSE/Xinhua China 25 Index: 20,055.65 |
CCM - OTHERS Related Party Transactions of a Revenue or Trading Nature
Company Name | CHEMICAL COMPANY OF MALAYSIA BERHAD |
Stock Name | CCM |
Date Announced | 7 Apr 2015 |
Category | General Announcement |
Reference No | CC-150323-50171 |
Type | Announcement | |||||||||||||||||||||||||
Subject | OTHERS | |||||||||||||||||||||||||
Description | Related Party Transactions of a Revenue or Trading Nature | |||||||||||||||||||||||||
1. INTRODUCTION The Board of Directors of Chemical Company of Malaysia Berhad (“CCM” or “the Company”) wishes to announce the following Related Party Transaction (“RPT”) entered into between the various CCM Group, for the sale of chemicals at a total value of RM13,692,551. 2. INFORMATION ON CHEMICAL COMPANY OF MALAYSIA BERHAD CCM was incorporated in CCM is an investment holding and management company with subsidiaries and an associate company engaged in the manufacturing, marketing and/ or supply of fertilizers, chemicals and pharmaceuticals products and services. 3. INFORMATION ON CCM USAHA KIMIA (M) SDN BHD (“CCMUK”) CCMUK was incorporated in Malaysia on 18 September 1989 as a private company limited by shares under the name of Usaha Kimia (M) Sdn Bhd and later assumed its present name on 3 July 2008. CCMUK is a wholly-owned subsidiary of the Company and is the holding company for CCM’s Chemicals Division. CCMUK is principally engage in trading as an agent in chemicals and other commodities. 4. INFORMATION ON CCM CHEMICALS SDN BHD (“CCMC”) CCM Chemicals Sdn Bhd (“CCMC”) was incorporated in CCMC is 80% owned by CCM Usaha Kimia (M) Sdn Bhd, a wholly-owned subsidiary of Chemical Company of Malaysia Berhad, and principally engaged in the manufacture and marketing of chlor-alkali and coagulant products and marketing of industrial and specialty chemicals. The other 20% of the paid-up capital of CCMC is held by Lanjut Setia Sdn Bhd (10%) and Permodalan Nasional Berhad (10%). 5. INFORMATION ON CCM INNOVATIVE SOLUTIONS SDN BHD (“CCMIS”) CCMIS is a private company limited by shares and was incorporated in Malaysia on 17 October 1995 under the name of Pacific Medicare Sdn Bhd and later assumed its present name on 20 January 2012. CCMIS is a wholly-owned subsidiary of the Company through CCMUK and CCMIS is principally engaged in the manufacturing and selling of industrial cleaner and hydrogel coating products. 6. INFORMATION ON CCM SINGAPORE PTE LTD (“CCMSPL”) CCMSPL was incorporated in Singapore on 8 August 1997 under the name of CCM Holdings Pte Ltd and later assumed its present name on 22 March 2002. CCMSPL is principally engaged in the marketing of chlor-alkali and coagulants products. CCM has an effective equity interest of 80% in CCMSPL through CCMC. 7. INFORMATION ON PT CCM INDONESIA (“PTCCMI”) PTCCMI was incorporated in Indonesia on 9 September 2002. CCMC directly holds 99.67% of the shares of PT CCMI whereas the remaining 0.33% is directly held by CCM Watercare Sdn Bhd, a wholly-owned subsidiary of CCM Chemicals Sdn Bhd. CCM has an effective equity interest of 80% in PTCCMI through CCMC. PTCCMI is principally engaged in the marketing of chemicals. 8. INFORMATION ON UPHA PHARMACEUTICAL MANUFACTURING (M) SDN BHD (“UPHA”) UPHA was incorporated in Malaysia on 28 December 1979 as a private company limited by shares. UPHA is a wholly-owned subsidiary of the Company and is principally engaged in the contract manufacturing of pharmaceutical products and sales of medicines. 9. BACKGROUND INFORMATION OF THE TRANSACTIONS The transaction is a related party transaction pursuant to paragraph 10.08 of the Main Market Listing Requirements of Bursa Malaysia Securities Berhad (“Bursa Securities”) in view of the interests of certain director of the Company. Nature of Transactions Vendor/ Provider Purchaser/ Recipient Actual Value transacted from 1 October 2014 (RM) Related Party Sale of Chemicals CCMC CCMUK 8,067,739 Interested Director/ Interested Person Connected: Leonard Ariff bin Abdul Shatar CCMC UPHA 52,204 CCMC CCMIS 731,501 CCMC CCMSPL 4,321,503 CCMC PTCCMI 375,841 CCMUK CCMC 143,763 During the last Annual General Meeting, mandate was not sought from the shareholders as the transactions were not regarded as related party transactions then. However, on 1 October 2014, Leonard Ariff bin Abdul Shatar (“LAAS”) has been appointed as the Acting Chief Executive Officer to replace the former Group Managing Director, Amirul Feisal bin Wan Zahir, and subsequently as the Group Managing Director of the Company. LAAS also holds the position of Division Director of Chemicals Division as well as, the Chief Executive Officer of CCM Duopharma Biotech Berhad i.e the Company’s Pharmaceuticals arm and has no direct interest in any companies within the CCM Group, nor its subsidiaries. Hence, by virtue of his position, LAAS is an interested director/ interested person connected. The transactions were done on terms which are not more favourable to the related party than those generally available to the public and are not to the detriment of the minority shareholders and they are conducted at arms’ length and on normal commercial terms consistent with the Group’s usual business practices and policies and will not be prejudicial to the shareholders 10. FINANCIAL EFFECT OF THE TRANSACTIONS (a)? Share Capital The transaction will not have any effect on the share capital of the Company and the shareholding of the substantial shareholders of the Company. (b) Net Assets The transaction will not have any material effect on the net assets of the CCM Group for the financial year ending 31 December 2015. (c) Earnings The transaction will not have any material effect on the earnings of the CCM Group for the financial year ending 31 December 2015. 11. INTERESTS OF DIRECTORS, MAJOR SHAREHOLDERS AND PERSONS CONNECTED Leonard Ariff bin Abdul Shatar is the Group Managing Director of CCM, Chief Executive Officer of CCM Duopharma Biotech Berhad and the Division Director of CCM’s Chemicals Division, and by virtue of him holding these positions, Leonard Ariff bin Abdul Shatar is an interested director/ interested person connected and is deemed interested in the transactions. Hence, Leonard Ariff bin Abdul Shatar has abstained and will continue to abstain from Board deliberations and voting on the transactions, in respect of his direct and indirect shareholdings in CCM (if any), and shall undertake to ensure that person(s) connected to him (if any) will also abstain from voting on the transactions. 12. STATEMENT BY THE AUDIT AND COMPLIANCE COMMITTEE The Audit and Compliance Committee has seen and reviewed the terms of the Related Party Transaction (“RPT”) and is satisfied that the procedures for RPT are sufficient to ensure that RPT will be made at arm’s length terms and in accordance with the Group’s normal commercial terms, and on terms which are not more favourable to the Related Party than those generally available to the public and hence, will not be detrimental to the minority shareholders or disadvantageous to the Group. 13. STATEMENT BY THE BOARD OF DIRECTORS’ The Board, after careful deliberation, is of the opinion that the transactions are in best interest of the Company and CCM Group.
14. DOCUMENTS FOR INSPECTION The relevant agreements in relation to the transactions are available for inspection at the Registered Office of the Company at 13th Floor, Menara PNB, 201-A Jalan Tun Razak, 50400 Kuala Lumpur during normal office hours for a period of one month from the date of this announcement. This announcement is dated 7 April 2015.
|
IJM - Additional Listing Announcement
Company Name | IJM CORPORATION BERHAD |
Stock Name | IJM |
Date Announced | 7 Apr 2015 |
Category | Additional Listing Announcement (ALA) |
Reference No | IC-150407-AEDC8 |
1. Details of Corporate Proposal | |
Whether the corporate proposal involves the issuance of new type and new class of securities? | No |
Types of corporate proposal | Others |
Details of corporate proposal | Issuance of shares for Employee Share Grant Plan |
No. of shares issued under this corporate proposal | 468,900 |
Issue price per share ($$) | MYR 5.450 |
Par Value ($$) | MYR 1.000 |
Latest issued and paid up share capital after the above corporate proposal in the following | |
Units | 1,779,982,110 |
Currency | MYR 1,779,982,110.000 |
Listing Date | 08/04/2015 |
ORIENT - Changes in Sub. S-hldr's Int. (29B) - Employees Provident Fund Board
Company Name | ORIENTAL HOLDINGS BERHAD |
Stock Name | ORIENT |
Date Announced | 7 Apr 2015 |
Category | Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965 |
Reference No | CC-150407-82361 |
Particulars of substantial Securities Holder
Name | Employees Provident Fund Board |
Address | Tingkat 19, Bangunan KWSP Jalan Raja Laut 50350 Kuala Lumpur |
NRIC/Passport No/Company No. | EPF ACT 1991 |
Nationality/Country of incorporation | Malaysia |
Descriptions (Class & nominal value) | Ordinary stocks of RM1.00 each |
Name & address of registered holder | Citigroup Nominees (Tempatan) Sdn Bhd for Employees Provident Fund Board Level 42, Menara Citibank, 165 Jalan Ampang 50450 Kuala Lumpur |
Details of changes
Currency: Malaysian Ringgit (MYR)
Type of transaction | Date of change | No of securities | Price Transacted (RM) |
Disposed | 02/04/2015 | 142,400 |
Remarks : |
This Notice was received on 7 April 2015. |
KSL - Additional Listing Announcement
Company Name | KSL HOLDINGS BERHAD |
Stock Name | KSL |
Date Announced | 7 Apr 2015 |
Category | Additional Listing Announcement (ALA) |
Reference No | CC-150403-45455 |
1. Details of Corporate Proposal | |
Whether the corporate proposal involves the issuance of new type and new class of securities? | No |
Types of corporate proposal | Others |
Details of corporate proposal | Conversion of Warrant 2011/2016 to Ordinary Shares |
No. of shares issued under this corporate proposal | 718,300 |
Issue price per share ($$) | MYR 0.800 |
Par Value ($$) | MYR 0.500 |
Latest issued and paid up share capital after the above corporate proposal in the following | |
Units | 953,431,993 |
Currency | MYR 476,715,996.500 |
Listing Date | 08/04/2015 |
GAMUDA - Additional Listing Announcement
Company Name | GAMUDA BERHAD |
Stock Name | GAMUDA |
Date Announced | 7 Apr 2015 |
Category | Additional Listing Announcement (ALA) |
Reference No | GG-150407-597B3 |
1. Details of Corporate Proposal | |
Whether the corporate proposal involves the issuance of new type and new class of securities? | No |
Types of corporate proposal | Others |
Details of corporate proposal | Conversion of Warrants (GAMUDA-WD) |
No. of shares issued under this corporate proposal | 393,100 |
Issue price per share ($$) | MYR 2.660 |
Par Value ($$) | MYR 1.000 |
Latest issued and paid up share capital after the above corporate proposal in the following | |
Units | 2,349,767,729 |
Currency | MYR 2,349,767,729.000 |
Listing Date | 08/04/2015 |
GAMUDA - Changes in Sub. S-hldr's Int. (29B) - Employees Provident Fund Board ("EPF Board")
Company Name | GAMUDA BERHAD |
Stock Name | GAMUDA |
Date Announced | 7 Apr 2015 |
Category | Changes in Substantial Shareholder's Interest Pursuant to Form 29B of the Companies Act. 1965 |
Reference No | GG-150407-8368D |
Particulars of substantial Securities Holder
Name | Employees Provident Fund Board ("EPF Board") |
Address | Tingkat 19, Bangunan KWSP, Jalan Raja Laut, 50350 Kuala Lumpur |
NRIC/Passport No/Company No. | EPF ACT 1991 |
Nationality/Country of incorporation | Malaysia |
Descriptions (Class & nominal value) | Ordinary shares of RM1.00 each |
Name & address of registered holder | Citigroup Nominees (Tempatan) Sdn Bhd - EPF Board |
Details of changes
Currency: Malaysian Ringgit (MYR)
Type of transaction | Date of change | No of securities | Price Transacted (RM) |
Disposed | 02/04/2015 | 800,000 |
Remarks : |
Notice was received on 7 April 2015. |
DIALOG - Additional Listing Announcement
Company Name | DIALOG GROUP BERHAD |
Stock Name | DIALOG |
Date Announced | 7 Apr 2015 |
Category | Additional Listing Announcement (ALA) |
Reference No | DG-150407-603C4 |
1. Details of Corporate Proposal | |
Whether the corporate proposal involves the issuance of new type and new class of securities? | No |
Types of corporate proposal | Others |
Details of corporate proposal | Conversion of warrants 2012/2017 to ordinary shares |
No. of shares issued under this corporate proposal | 47,073 |
Issue price per share ($$) | MYR 1.190 |
Par Value ($$) | MYR 0.100 |
Latest issued and paid up share capital after the above corporate proposal in the following | |
Units | 5,054,341,892 |
Currency | MYR 505,434,189.200 |
Listing Date | 08/04/2015 |
YOKO - TAKE-OVERS & MERGERS (CHAPTER 11 OF LISTING REQUIREMENTS)
Company Name | YOKOHAMA INDUSTRIES BERHAD |
Stock Name | YOKO |
Date Announced | 7 Apr 2015 |
Category | General Announcement |
Reference No | CC-150407-D161D |
Type | Announcement |
Subject | TAKE-OVERS & MERGERS (CHAPTER 11 OF LISTING REQUIREMENTS) |
Description | YOKOHAMA INDUSTRIES BERHAD (“YOKOHAMA” OR “THE COMPANY”) UNCONDITIONAL TAKE-OVER OFFER BY FORDINGTON PTE LTD (“FORDINGTON” OR “OFFEROR”) THROUGH MERCURY SECURITIES SDN BHD TO ACQUIRE ALL THE REMAINING ORDINARY SHARES OF RM0.50 EACH IN YOKOHAMA (“YOKOHAMA SHARES”) (EXCLUDING TREASURY SHARES) NOT ALREADY HELD BY THE OFFEROR AND PERSONS ACTING IN CONCERT WITH IT (“PACs”) (“OFFER SHARES”) AT A CASH OFFER PRICE OF RM1.70 PER OFFER SHARE (“OFFER”) |
Pursuant to Section 33(1) of the Malaysian Code on Take-Overs and Mergers, 2010, Yokohama wishes to announce that Fordington Pte Ltd being the Offeror for the Offer, has dealt in the Yokohama's ordinary shares of RM0.50 each for its own account on 6 April 2015. Please refer to the press release for further details. This announcement is dated 7 April 2015. |
No comments:
Post a Comment